First American Bank’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.74M | Hold |
29,567
| – | – | 0.21% | 83 |
|
|
2026
Q1 | $4.12M | Hold |
29,567
| – | – | 0.26% | 70 |
|
|
2025
Q4 | $3.63M | Sell |
29,567
-30
| -0.1% | -$3.65K | 0.22% | 79 |
|
|
2025
Q3 | $3.29M | Sell |
29,597
-165
| -0.6% | -$18.8K | 0.21% | 82 |
|
|
2025
Q2 | $3.3M | Hold |
29,762
| – | – | 0.23% | 79 |
|
|
2025
Q1 | $3.33M | Hold |
29,762
| – | – | 0.25% | 77 |
|
|
2024
Q4 | $2.75M | Sell |
29,762
-38
| -0.1% | -$3.42K | 0.19% | 83 |
|
|
2024
Q3 | $2.5M | Sell |
29,800
-409
| -1% | -$31.2K | 0.18% | 87 |
|
|
2024
Q2 | $2.07M | Hold |
30,209
| – | – | 0.16% | 94 |
|
|
2024
Q1 | $2.21M | Hold |
30,209
| – | – | 0.17% | 96 |
|
|
2023
Q4 | $2.45M | Sell |
30,209
-325
| -1% | -$25.3K | 0.2% | 91 |
|
|
2023
Q3 | $2.29M | Buy |
30,534
+396
| +1% | +$30.5K | 0.21% | 92 |
|
|
2023
Q2 | $2.32M | Hold |
30,138
| – | – | 0.2% | 92 |
|
|
2023
Q1 | $2.5M | Sell |
30,138
-535
| -2% | -$44.3K | 0.23% | 90 |
|
|
2022
Q4 | $2.63M | Buy |
30,673
+101
| +0.3% | +$8K | 0.25% | 83 |
|
|
2022
Q3 | $1.89M | Buy |
30,572
+132
| +0.4% | +$8.32K | 0.2% | 98 |
|
|
2022
Q2 | $1.88M | Sell |
30,440
-234
| -0.8% | -$14.5K | 0.19% | 98 |
|
|
2022
Q1 | $1.82M | Hold |
30,674
| – | – | 0.15% | 109 |
|
|
2021
Q4 | $2.23M | Hold |
30,674
| – | – | 0.12% | 139 |
|
|
2021
Q3 | $2.14M | Sell |
30,674
-740
| -2% | -$52K | 0.12% | 139 |
|
|
2021
Q2 | $2.16M | Sell |
31,414
-335
| -1% | -$22.4K | 0.13% | 137 |
|
|
2021
Q1 | $2.05M | Sell |
31,749
-261
| -0.8% | -$16.8K | 0.13% | 137 |
|
|
2020
Q4 | $1.86M | Sell |
32,010
-15,903
| -33% | -$960K | 0.12% | 135 |
|
|
2020
Q3 | $3.03M | Sell |
47,913
-20
| -0% | -$1.39K | 0.18% | 124 |
|
|
2020
Q2 | $3.69M | Hold |
47,933
| – | – | 0.23% | 110 |
|
|
2020
Q1 | $3.58M | Sell |
47,933
-21,405
| -31% | -$1.48M | 0.27% | 104 |
|
|
2019
Q4 | $4.51M | Buy |
+69,338
| New | +$4.52M | 0.28% | 102 |
|
|
2019
Q2 | $4.72M | Sell |
69,833
-769
| -1% | -$50.6K | 0.32% | 89 |
|
|
2019
Q1 | $4.59M | Sell |
70,602
-473
| -0.7% | -$31.4K | 0.33% | 88 |
|
|
2018
Q4 | $4.45M | Sell |
71,075
-660
| -0.9% | -$46.1K | 0.35% | 82 |
|
|
2018
Q3 | $5.54M | Buy |
+71,735
| New | +$5.42M | 0.38% | 74 |
|
|
2018
Q1 | $5.39M | Buy |
71,538
+681
| +1% | +$54.1K | 0.41% | 73 |
|
|
2017
Q4 | $5.08M | Sell |
70,857
-629
| -0.9% | -$47.8K | 0.39% | 76 |
|
|
2017
Q3 | $5.79M | Sell |
71,486
-2,815
| -4% | -$215K | 0.44% | 71 |
|
|
2017
Q2 | $5.26M | Buy |
74,301
+12,352
| +20% | +$822K | 0.42% | 71 |
|
|
2017
Q1 | $4.21M | Sell |
61,949
-26,308
| -30% | -$1.85M | 0.34% | 84 |
|
|
2016
Q4 | $6.32M | Sell |
88,257
-6,423
| -7% | -$477K | 0.53% | 50 |
|
|
2016
Q3 | $7.49M | Sell |
94,680
-5,325
| -5% | -$433K | 0.69% | 32 |
|
|
2016
Q2 | $8.34M | Sell |
100,005
-22,273
| -18% | -$1.98M | 0.8% | 28 |
|
|
2016
Q1 | $11.2M | Sell |
122,278
-38,943
| -24% | -$3.51M | 1.11% | 21 |
|
|
2015
Q4 | $16.3M | Sell |
161,221
-5,893
| -4% | -$613K | 1.66% | 13 |
|
|
2015
Q3 | $16.4M | Buy |
167,114
+334
| +0.2% | +$37.1K | 1.8% | 10 |
|
|
2015
Q2 | $19.5M | Sell |
166,780
-32,279
| -16% | -$3.53M | 1.93% | 11 |
|
|
2015
Q1 | $19.5M | Sell |
199,059
-2,317
| -1% | -$235K | 1.92% | 12 |
|
|
2014
Q4 | $19M | Sell |
201,376
-37,642
| -16% | -$3.89M | 2.01% | 10 |
|
|
2014
Q3 | $25.4M | Sell |
239,018
-6,355
| -3% | -$622K | 2.77% | 8 |
|
|
2014
Q2 | $20.3M | Sell |
245,373
-2,135
| -0.9% | -$166K | 2.19% | 10 |
|
|
2014
Q1 | $17.5M | Buy |
247,508
+1,692
| +0.7% | +$133K | 1.95% | 13 |
|
|
2013
Q4 | $18.5M | Sell |
245,816
-1,035
| -0.4% | -$72.1K | 2.11% | 12 |
|
|
2013
Q3 | $15.5M | Sell |
246,851
-1,222
| -0.5% | -$73K | 1.91% | 12 |
|
|
2013
Q2 | $12.7M | Buy |
+248,073
| New | +$12.9M | 1.77% | 14 |
|
Other funds holding GILD
LMFP
CIM
ATO
CGH
First American Bank's GILD Position: Q2 2026 in Review
First American Bank held its Gilead Sciences (GILD) position steady in Q2 2026 at 29,567 shares worth $3.74M. The position accounts for 0.21% of the portfolio, ranked #83.
First American Bank first reported a position in GILD in Q2 2013 and has held it in 51 quarters since. The position peaked at $25.4M in Q3 2014. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- First American Bank held 29,567 shares of Gilead Sciences worth $3.74M as of Q2 2026.
- First American Bank left its Gilead Sciences share count unchanged in Q2 2026.
- Gilead Sciences made up 0.21% of First American Bank's portfolio in Q2 2026, its #83 holding.
- First American Bank first reported a position in Gilead Sciences in Q2 2013 and has held it in 51 quarters since.
- First American Bank's Gilead Sciences position peaked at $25.4M in Q3 2014.
- 690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on First American Bank's 13F filing for Q2 2026, filed 15 Jul 2026.